Dual-target mu opioid-dopamine D3 receptor (MOR-D3R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesics.
Saved in:
| Title: | Dual-target mu opioid-dopamine D |
|---|---|
| Authors: | Jahan K; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Glatfelter G; Designer Drug Research Unit, NIDA-IRP, Baltimore, MD, USA., Sanchez J; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, Midlands, UK., Maitland AD; Designer Drug Research Unit, NIDA-IRP, Baltimore, MD, USA., Bonifazi A; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA; Department of Pharmacology and Toxicology, Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX, USA., Saab E; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Keegan BM; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Rais R; Johns Hopkins Drug Discovery Program, Johns Hopkins School of Medicine, Baltimore, MD, USA., Bi GH; Addiction Biology Unit, Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, NIDA-IRP, Baltimore, MD, USA., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, NIDA-IRP, Baltimore, MD, USA., Xi ZX; Addiction Biology Unit, Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Lane JR; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, Midlands, UK., Canals M; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, Midlands, UK., Baumann MH; Designer Drug Research Unit, NIDA-IRP, Baltimore, MD, USA., Newman AH; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA. Electronic address: anewman@intra.nida.nih.gov. |
| Source: | European journal of medicinal chemistry [Eur J Med Chem] 2026 Jun 22; Vol. 317, pp. 119079. Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
